- Home
- ATR vs AXSM Comparison
ATR vs AXSM Comparison
Compare ATR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATR | AXSM |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.0B |
| IPO Year | 1993 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ATR | AXSM |
|---|---|---|
| Price | $124.72 | $177.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 21 |
| Target Price | $167.50 | ★ $186.71 |
| AVG Volume (30 Days) | 449.1K | ★ 806.9K |
| Earning Date | 02-05-2026 | 02-17-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | ★ 24.99 | N/A |
| EPS | ★ 6.23 | N/A |
| Revenue | ★ $3,662,533,000.00 | $561,263,000.00 |
| Revenue This Year | $3.97 | $67.10 |
| Revenue Next Year | $3.36 | $58.73 |
| P/E Ratio | $20.02 | ★ N/A |
| Revenue Growth | 2.50 | ★ 65.83 |
| 52 Week Low | $103.23 | $86.99 |
| 52 Week High | $164.28 | $184.40 |
Technical Indicators
Market Signals| Indicator | ATR | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 55.68 | 64.85 |
| Support Level | $122.54 | $172.73 |
| Resistance Level | $127.22 | $179.00 |
| Average True Range (ATR) | 2.73 | 7.45 |
| MACD | 0.33 | 0.49 |
| Stochastic Oscillator | 75.23 | 82.31 |
Price Performance
Historical ComparisonAbout ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.